
The Market for RNA Sequencing, 2nd Edition
Description
The Market for RNA Sequencing, 2nd Edition
The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future. In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas. In recent years, the use of microarrays for RNA expression analysis has dropped greatly as RNA sequencing has risen to replace and outshine it. Similar to quantitative reverse transcription-PCR (q-RT-PCR) which has been the gold standard, there is a need for pre-defined probes which creates one of the major weaknesses of microarrays, and RNA-seq provides a number of advantages including:
Information in this report includes:
Companies Profiled Include:
The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future. In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas. In recent years, the use of microarrays for RNA expression analysis has dropped greatly as RNA sequencing has risen to replace and outshine it. Similar to quantitative reverse transcription-PCR (q-RT-PCR) which has been the gold standard, there is a need for pre-defined probes which creates one of the major weaknesses of microarrays, and RNA-seq provides a number of advantages including:
- improved sensitivity and dynamic range
- ability to study species without reference
- measurement of focal changes (such as single nucleotide variants, insertions and deletions)
- detection of different transcript isoforms, splice variants and chimeric gene fusions (including previously unidentified genes and/or transcripts)
Information in this report includes:
- RNA Sequencing Market, 2021 and 2026
- RNA Sequencing Consumables Market, 2021 and 2026
- RNA Sequencing Equipment-Related Services Market, 2021 and 2026
- RNA Sequencing Software Market, 2021 and 2026
- RNA Sequencing Vendor Share
- Products on The Market
- Software Products
- Innovations
- Clinical Sequencing and Products on the Market
Companies Profiled Include:
- Illumina
- Agilent
- 10X Genomics
- Oxford Nanopore
- Thermo
- Roche
- Qiagen
- and Others
Table of Contents
59 Pages
- RNA Sequencing Revenues by Product Segment (Consumables, Systems/Hardware, Service, and Software), 2021 (in millions of $)
- RNA Sequencing Revenues by Product Segment (Consumables, Systems/Hardware, Service, and Software), 2021 (percent)
- Scope and Methodology
- Introduction
- Trends
- Ongoing Introductions of New Products
- Single-Cell RNA Sequencing
- Software/ Bioinformatics
- Partnerships, Acquisitions, Deals in Many Areas
- Market Analysis
- Market Shares
- llumina
- Thermo Fisher Scientific
- New England Biolabs
- 10X Genomics
- Agilent Technologies
- Takara Bio Inc.
- Oxford Nanopore Technologies
- NuGen (Tecan)
- Pacific Biosciences of California, Inc. (PacBio)
- Standard BioTools
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.